Microwave-assisted (radio)halogenation of nitroimidazole-based Hypoxia markers

Applied Radiation and Isotopes

Volumn 57, Issue 5, 2002, Pages 697-703

  Kumar, P ^a   Wiebe, L I ^a   Asikoglu, M ^a   Tandon, M ^a   McEwan, A J B ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b CROSS CANCER INSTITUTE   (Canada)

Author keywords

azomycin nucleosides; (radio)halogenation; Hypoxia markers; Microwave

Indexed keywords

HALOGENATION; MICROWAVES; RADIOLOGY; SUBSTITUTION REACTIONS; SYNTHESIS (CHEMICAL);

RADIOLABELLING;

DRUG PRODUCTS;

1 ALPHA DEXTRO [5' DEOXY 5' FLUOROARABINOFURANOSYL] 2 NITROIMIDAZOLE; 1 ALPHA DEXTRO [5' DEOXY 5' IODOARABINOFURANOSYL] 2 NITROIMIDAZOLE; 1 ALPHA LEVO [4' DEOXY 4' IODOXYLOPYRANOSYL] 2 NITROIMIDAZOLE; 2 NITROIMIDAZOLE DERIVATIVE; BIOCHEMICAL MARKER; HALOGEN; UNCLASSIFIED DRUG;

ARTICLE; DRUG SYNTHESIS; HALOGENATION; HYPOXIA; INTERMETHOD COMPARISON; ISOTOPE LABELING; MICROWAVE RADIATION; PRIORITY JOURNAL; SUBSTITUTION REACTION;

ANOXIA; BIOLOGICAL MARKERS; HEAT; HUMANS; IODINE RADIOISOTOPES; ISOTOPE LABELING; MICROWAVES; NITROIMIDAZOLES; RADIOCHEMISTRY; RADIOPHARMACEUTICALS;

EID: 0036842054     PISSN: 09698043     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8043(02)00185-9     Document Type: Article

References (15)

1. Al-Arafaj A., Ryan E.A., Hutchinson K., Mannan R.H., Mercer J.R., Wiebe L.I., McEwan A.J.B. An evaluation of iodine-123 iodoazomycin arabinoside as a marker of localized tissue hypoxia in patients diabetes mellitus. Eur. J. Nucl. Med. 21:1994;1338-1342.
2. Biaglow J.E., Varnes M.E., Rizen-Towle L., Clark E.P., Epp F.R., Astor M.B., Hall E.J. Biochemistry of reduction of nitroheterocycles. Biochem. Pharmacol. 35:1986;77.
3. Gedye R., Smith F., Westaway K., Ali H., Baldisera L., Laberge L., Rousell J. The use of microwave ovens for rapid organic synthesis. Tetrahedron Lett. 27:1986;279.
4. Grosher D., McEwan A.J.B., Parliament M.B., Urtasun R.C., Goldberg L.E., Hoskinson M., Mercer J.R., Mannan R.H., Wiebe L.I., Chapman J.D. Imaging tumor Hypoxia and tumor perfusion. J. Nucl. Med. 34:1993;885.
5. 18F]-Spiperone. J. Lab. Compd. Radiopharm. 26:1989;391. (Abstract).
6. 3H-labelling and preliminary biological evaluation of a novel 2-nitroimidazole marker of tissue hypoxia J. Labelled Compd. Radiopharm. 42:1999;3-16.
7. 18F]-FAZA: A putative PET radiotracer for hypoxia in: Ulrich Pleiss, Rolf Voges (Eds.) Synthesis and Applications of Isotopically Labelled Compounds 2000. Wiley, UK.
8. Lemaire C., Cantineau R., Christiaens L., Guillaume M. Radiofluorination of Altanserine a potential serotonin receptor binding radiopharmaceutical for positron emission tomography. J. Lab. Compd. Radiopharm. 36:1989;336. (Abstract).
9. Mannan, R.H., 1991. Novel non-invasive markers of tumor hypoxia. Ph.D. Thesis, University of Alberta, Edmonton, Canada, pp. 53-58.
10. Mannan R.H., Somayaji V.V., Lee J., Mercer J.R., Chapman J.D., Wiebe L.I. Radioiodinated 1-(5-Iodo-5-deoxy-β-D-arabinofuranosyl)-2-nitroimidazole (Iodoazomycin Arabinoside: IAZA), a Novel Marker of Tissue Hypoxia. J. Nucl. Med. 32:1991;1764-1770.
11. Mannan R.H., Mercer J.R., Wiebe L.I., Kumar P., Somayaji V.V., Chapman J.D. Radioiodinated azomycin pyranoside (IAZP). a novel non-invasive marker for the assessment of tumor hypoxia J. Nucl. Biol. Med. 36:1992;60-67.
12. McEwan A.J.B., Skeith K.J., Mannan R.H., Davies N., Jamali F., Schmidt R., Golberg K., Wiebe L.I. I-123 Iodoazomycin arabinoside (IAZA) may have a role in imaging rheumatoid arthritis. J. Nucl. Med. 38:1997;300.
13. 123I-iodoazomycin arabinoside. preliminary report of a clinical study Br. J. Cancer. 65:1992;90-95.
14. 18F]Fluoroazomycin-arabinosid (FAZA), ein neuer Radiotracer zur Bestimmung von Gewebe-Hypoxien. International Annual Conference, Deut. G. Nuklearmed. Ulm, Germany.
15. Urtasun R.C., McEwan A.J., Parliament M.B., Mercer J.R., Mannan R.H., Wiebe L.I., Morin C., Chapman J.D. Measurement of hypoxia in human tumours by non-invasive spect imaging of iodoazomycin arabinoside. Br. J. Cancer. 74:1996;S209.